Renhe Weilai (Genetalks)
PrivateLast Round
Series A
Jul 1, 2017
Est. Valuation
$406.09M
Total Funding Raised
$36.92M
Company Overview
Renhe Weilai (Genetalks) is a biotechnology company that provides high-performance computing and artificial intelligence solutions for genetic big data analysis and management.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Renhe Weilai (Genetalks) Comparables
Compare Renhe Weilai (Genetalks) with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sentieon Inc. | 79% | |
| MGI | 77% | |
| DNAnexus | 77% |
Renhe Weilai (Genetalks) Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 1, 2017 |
Renhe Weilai (Genetalks) Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jiawo Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2017
$37M round led by Jiawo Capital.
Renhe Weilai (Genetalks) Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Renhe Weilai (Genetalks)'s valuation, stock price, and market status.
Is Renhe Weilai (Genetalks) a public or private company?
Renhe Weilai (Genetalks) is a private company.
What is the current stock price of Renhe Weilai (Genetalks)?
Renhe Weilai (Genetalks) is a private company with no public stock price. Caplight tracks Renhe Weilai (Genetalks)'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Renhe Weilai (Genetalks) worth (valuation)?
Renhe Weilai (Genetalks)'s valuation is estimated at $406.1M based on funding round data.
Can I buy Renhe Weilai (Genetalks) stock?
Renhe Weilai (Genetalks) shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Renhe Weilai (Genetalks)'s last funding round?
Renhe Weilai (Genetalks)'s most recent funding round was Series A on July 1, 2017.
Who are the main investors in Renhe Weilai (Genetalks)?
Key investors in Renhe Weilai (Genetalks) include Jiawo Capital.
Will Renhe Weilai (Genetalks) IPO soon?
No public IPO plans have been announced for Renhe Weilai (Genetalks).
How can I track Renhe Weilai (Genetalks) secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Renhe Weilai (Genetalks)'s secondary market activity and sign up for updates.